Effect of extended cefquinome treatment on clinical persistence or recurrence of environmental clinical mastitis

Veterinary Journal

Volumn 197, Issue 3, 2013, Pages 682-687

  Swinkels, J M ^a   Lam, T J G M ^a,b   Green, M J ^c   Bradley, A J ^c,d  

^a GD ANIMAL HEALTH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d Quality Milk Management Services Ltd   (United Kingdom)

Author keywords

Antibiotic; Bovine; Extended treatment; Lactation; Mammary gland

Indexed keywords

CEFQUINOME; COBACTAN LC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOVINE MASTITIS; CLINICAL FEATURE; CONTROLLED STUDY; COW; DAIRYING; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; ESCHERICHIA COLI; INTRAMAMMARY DRUG ADMINISTRATION; MORNING DOSAGE; NONHUMAN; PERSISTENT INFECTION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; STREPTOCOCCUS UBERIS;

BOVINAE;

ANTIBIOTIC; BOVINE; EXTENDED TREATMENT; LACTATION; MAMMARY GLAND;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; MASTITIS, BOVINE; RECURRENCE;

EID: 84884978034     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.03.010     Document Type: Article

References (31)

1. Bar D., Gröhn Y.T., Bennett G., Gonzalez R.N., Hertl J.A., Schulte H.F., Tauer L.W., Welcome F.L., Schukken Y.H. Effect of repeated episodes of generic clinical mastitis on milk yield in dairy cows. Journal of Dairy Science 2007, 90:4643-4653.
2. Bar D., Tauer L.W., Bennett G., Gonzalez R.N., Hertl J.A., Schukken Y.H., Schulte H.F., Welcome F.L., Gröhn Y.T. The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming. Journal of Dairy Science 2008, 91:2205-2214.
3. Barlow J.W., White L.J., Zadoks R.N., Schukken Y.H. A mathematical model demonstrating indirect and overall effects of lactation therapy targeting subclinical mastitis in dairy herds. Preventive Veterinary Medicine 2009, 90:31-42.
4. Bradley A.J., Green M.J. Adaptation of Escherichia coli to the bovine mammary gland. Journal of Clinical Microbiology 2001, 39:1845-1849.
5. Browne W.J., Draper D. A comparison of Bayesian and likelihood-based methods for fitting multilevel models. Bayesian Analysis 2006, 1:473-514.
6. Döpfer D., Barkema H.W., Lam T.J.G.M., Schukken Y.H., Gaastra W. Recurrent clinical mastitis caused by Escherichia coli in dairy cows. Journal of Dairy Science 1999, 82:80-85.
7. Ehinger A.M., Schmidt H., Kietzmann M. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder. The Veterinary Journal 2006, 172:147-153.
8. Erskine R.J., Bartlett P.C., VanLente J.L., Phipps C.R. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. Journal of Dairy Science 2002, 85:2571-2575.
9. Gelman A., Meng X.L., Stern H. Posterior predictive assessment of model fitness via realized discrepancies. Statistica Sinica 1996, 6:733-807.
10. Green M.J., Burton P.R., Green L.E., Schukken Y.H., Bradley A.J., Peeler E.J., Medley G.F. The use of Markov chain Monte Carlo for analysis of correlated binary data: Patterns of somatic cells in milk and the risk of clinical mastitis in dairy cows. Preventive Veterinary Medicine 2004, 16:157-174.
11. Green M.J., Bradley A.J., Medley G.F., Browne W.J. Cow, farm and management factors during the dry period that determine the rate of clinical mastitis after calving. Journal of Dairy Science 2007, 90:3764-3776.
12. Houben E.H.P., Dijkhuizen A.A., van Arendonk J.A.M., Huirne R. Short- and long-term production losses and repeatability of clinical mastitis in dairy cattle. Journal of Dairy Science 1993, 76:2561-2578.
13. Lam T.J.G.M., Lipman L.J., Schukken Y.H., Gaastra W., Brand A. Epidemiological characteristics of bovine clinical mastitis caused by Staphylococcus aureus and Escherichia coli studied by DNA fingerprinting. American Journal of Veterinary Research 1996, 57:39-42.
14. Milne M.H., Biggs A.M., Barrett D.C., Young F.J., Doherty S., Innocent G.T., Fitzpatrick J.L. Treatment of persistent intramammary infections with Streptococcus uberis in dairy cows. Veterinary Record 2005, 157:245-250.
15. NMC, 1999. Laboratory Handbook on Bovine Mastitis. National Mastitis Council Inc., Madison, WI.
16. Oliver S.P., Almeida R.A., Gillespie B.E., Headrick S.J., Dowlen H.H., Johnson D.L., Lamar K.C., Chester S.T., Moseley W.M. Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle. Journal of Dairy Science 2004, 87:3322-3329.
17. Pinzón-Sánchez C., Ruegg P.L. Risk factors associated with short-term post-treatment outcomes of clinical mastitis. Journal of Dairy Science 2011, 94:3397-3410.
18. Pyörälä S.H., Pyörälä E.O. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows. Journal of the American Veterinary Medical Association 1998, 212:407-412.
19. Quinn P.J., Carter M.E., Markey B., Carter G.R. Clinical Veterinary Microbiology 1994, Wolfe, London, England.
20. Rasbash, J., Browne, W.J., Healy, M., Cameron, B., Charlton, C., 2010. MLwiN Version 2.22. In Multilevel Models Project. Centre for Multilevel Modelling, Bristol.
21. Schukken, Y.H., Dogan, B., Klaessig, S., Simpson, K., Almeida, R., Srinivasan, V., Gillespie, B., Oliver, S., 2004. Chronic and recurrent coliforms, implications for lactation therapy. In: Proceedings of the Annual Meeting of the National Mastitis Council, pp. 35-40.
22. Sérieys F., Raguet Y., Goby L., Schmidt H., Friton G. Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. Journal of Dairy Science 2005, 88:93-99.
23. Shpigel Y., Levin D., Winkler M., Saran A., Ziv G., Böttner A. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. Journal of Dairy Science 1997, 80:318-323.
24. Sol J., Sampimon O.C., Barkema H.W., Schukken Y.H. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. Journal of Dairy Science 2000, 83:278-284.
25. Spiegelhalter, D.J., Thomas, A., Best, N., 2004. WinBUGS Version 1.4.1. MRC, Biostatistics Unit, Cambridge, UK.
26. Swinkels J.M., Hogeveen H., Zadoks R.N. A partial budget model to estimate economic benefits of lactational treatment of subclinical Staphylococcus aureus mastitis. Journal of Dairy Science 2005, 88:4273-4287.
27. Swinkels J.M., Rooijendijk J.G.A., Zadoks R.N., Hogeveen H. Use of partial budgeting to determine the economic benefits of antibiotic treatment of chronic subclinical mastitis caused by Streptococcus uberis or Streptococcus dysgalactiae. Journal of Dairy Research 2005, 72:75-85.
28. Van Eenennaam A.L., Gardner A., Holmes J., Perani J.L., Anderson R.J., Cullor J.S., Guterbocks W.U. Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. Journal of Dairy Science 1995, 78:2086-2095.
29. Wenz J.R., Barrington G.M., Garry F.B., McSweeney K.D., Dinsmore R.P., Goodell G., Callan R.J. Bacteraemia associated with naturally occurring acute coliform mastitis in dairy cows. Journal of the American Veterinary Medical Association 2001, 219:976-981.
30. Wenz J.R., Garry F.B., Lombard J.E., Elia R., Prentice D., Dinsmore R.P. Short communication: Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle. Journal of Dairy Science 2005, 88:3496-3499.
31. Zadoks R.N., Allore H.G., Barkema H.W., Sampimon O.C., Wellenberg G.J., Gröhn Y.T., Schukken Y.H. Cow- and quarter-level risk factors for Streptococcus uberis and Staphylococcus aureus mastitis. Journal of Dairy Science 2001, 84:2649-2663.